{"date":"2026-07-12","count":2,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4737-2026-07-12-1648-11yed5g","company_id":"4737","company":"華廣","market":"上市","industry":"生技醫療","date":"2026-07-12","time":"16:48:35","subject":"公告本公司「連續葡萄糖監測系統(CGM)」通過歐盟醫療器材法規MDR認證","clause":"第51款","fact_date":"2026-07-10","cite_as":"公開資訊觀測站重大訊息：華廣（4737），2026-07-12 16:48，「公告本公司「連續葡萄糖監測系統(CGM)」通過歐盟醫療器材法規MDR認證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-07-12-1400-1af8b1b","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-07-12","time":"14:00:10","subject":"歐洲藥品管理局核准本公司授權夥伴Sandoz提交生物相似藥EG12014（trastuzumab biosimilar）420 mg劑量包裝變更申請","clause":"第10款","fact_date":"2026-07-09","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-07-12 14:00，「歐洲藥品管理局核准本公司授權夥伴Sandoz提交生物相似藥EG12014（trastuzumab biosimilar）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}